Skip to main content

Skin Products

Volume 226: debated on Monday 7 June 1993

The text on this page has been created from Hansard archive content, it may contain typographical errors.

To ask the Secretary of State for Health, pursuant to her answer of 12 May, Official Report, column 486, what consideration the Advisory Committee on NHS Drugs has given to drugs that have not been licensed by the Medicines Control Agency; and what mechanism will be used under the selected list scheme for the provision to NHS patients of skin products that do not require a product licence under the Medicines Act 1968.

The Advisory Committee is free to consider all drugs, including those which have not been licensed by the Medicines Control Agency. It will ensure that drugs to meet all real clinical needs can be provided as economically as possible under the national health service.